Interim analysis of the PARADISE study: benefits of add-on peginterferon-α in NA-treated patients with CHB.
Jiang S, Guo S, Huang Y, Xu J, Li Y, Zeng Y, Guo Y, Ouyang L, Zhu C, Zhao W, Zhang Q, Guo Q, Xin H, Xie Q.
Jiang S, et al. Among authors: guo q.
Antiviral Res. 2024 Apr 23:105892. doi: 10.1016/j.antiviral.2024.105892. Online ahead of print.
Antiviral Res. 2024.
PMID: 38663455